Polycystic Ovarian Syndrome

last authored: March 2011, David LaPierre
last reviewed:

 

 

 

Introduction

Polycystic ovarian syndrome (PCOS) is an endocrine imbalance affecting 5-10% of women of reproductive age, with average onset at 15-35 years. It is characterized by chronic anovulation, as well as symptoms such as obesity, hirsuitism, and virilization. While the exact cause is unknown, gonadotropin dysfunction is commonly seen.

 

 

 

The Case of Karen L.

Karen is a 34 year-old woman who comes to you with a history of irregular periods over the past year. She has been trying to get pregnant for the past three years. Given her history, and obesity, you wonder if she might have PCOS.

return to top

 

 

 

Causes and Risk Factors

There are many conditions that can co-esist with PCOS, and it is difficult to know which causes which:

return to top

 

 

 

Pathophysiology

Insulin resistance, and increased insulin levels, lead to elevated androgen production by the ovary, especially in patients with a genetic susceptibility.

 

Obesity leads to increased aromatase conversion to estrogen, which decreases FSH secretion and increases that of LH by acting on the pituitary. Increased ovarian secretion of androgens ensues, leading to hirsutism.

 

Gonadotropin dysfunction is usually seen, with an increased lutenizing hormone (LH) to follicular stimulating hormone (FSH) ratio. These appear to be mediated by deregulation of insulin and androgen, and also leads to increased testosterone production.

 

Increased LH and decreased FSH leads to anovulation, multiple cysts, oligomenorrhea, and infertility.

return to top

 

 

 

Signs and Symptoms

A diagnosis requires two of the following three:

  • history
  • physical exam

History

Symptoms of PCOS include:

  • amenorrhea (50%)
  • abnormal uterine bleeding (30%)
  • infertility

Past medical history

  • acne
  • gestational diabetes
  • hypertension
  • complete menstrual history

A family history of diabetes may be present.

Physical Exam

Vital signs: hypertension

Height, weight, and body mass index (BMI) should be ascertained.

Head and neck:

  • acne
  • hirsuitism
  • deepened voice

Skin

  • acanthosis nigricans, or the browning of skin folds, may also be present
  • changes in hair pattern and growth

Genitalia:

  • clitoromegaly

 

return to top

 

 

 

Investigations

  • lab investigations
  • diagnostic imaging

Lab Investigations

Testing should include:

  • fasting glucose, or oral glucose tolerance
  • hCG
  • TSH
  • prolactin
  • FSH (to exclude premature ovarian failure)
  • DHEAS and free testosterone are frequently increased; this is the most sensitive test
  • 17-OH progesterone if congenital adrenal hyperplasia is suspected
  • overnight dexamethasone suppression test to rule out Cushing syndrome
  • endometrial biopsy to rule out hyperplasia/carcinoma

LH:FSH is increasingly believed to be of little or no value, though some still believe a 2:1 ratio may be helpful in diagnosis.

Diagnostic Imaging

Transvaginal ultrasound can show polycystic ovaries appearing like a string of pearls.

Laparoscopy is not necessary, but shows a white ovary with multiple follicular cysts.

return to top

 

 

 

Differential Diagnosis

Anovulation may be also be seen in:

The differential of anovulation, polycustic ovaries, and high androgen levels can also be seen with:

return to top

 

 

 

Treatments

Treatment depends on specific concern for patient.

 

Non-medications

If the patient is obese, weight-loss through excercise and diet is critical to reduce peripheral production of estrogen. Hirsuitism can be treated with hair removal, such as epilation or electrolysis.

 

 

Medications

If the patient wishes to become pregnant, ovulation may be induced by clomiphene citrate - an estrogen receptor blocker which works on the hypothalamus to induce LH/FSH. Oral hypoglycemics, ie metformin, reduce insulin resistance and can also induce ovulation. In vitro fertilization remains an option.

 

OCP or cyclic Provera can be used to prevent endometrial hyperplasia from excess levels of estrogen, as well as reduce hirsutism.

 

Spironolactone, dexamethasone, finasteride, or flutamide may all be used to reduce excess androgen production. These can be teratogenic, however, and should be used with caution.

return to top

 

 

 

Consequences and Course

Consequences include:

return to top

 

 

 

Resources and References

 

return to top

 

 

Topic Development

authors:

reviewers:

 

return to top